Effects of antiepileptic drugs on learning as assessed by a repeated acquisition of response sequences task in rats

Epilepsy and Behavior

Volumn 10, Issue 1, 2007, Pages 16-25

  Shannon, Harlan E ^a   Love, Patrick L ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Antiepileptic drugs; Carbamazepine; Lamotrigine; Learning; Levetiracetam; Phenobarbital; Phenytoin; Repeated acquisition performance; Tiagabine; Topiramate; Valproate

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CHLORDIAZEPOXIDE; ETIRACETAM; LAMOTRIGINE; MUSCARINIC RECEPTOR BLOCKING AGENT; PHENOBARBITAL; PHENYTOIN; SCOPOLAMINE; SODIUM CHANNEL BLOCKING AGENT; TIAGABINE; TOPIRAMATE; TRIAZOLAM; VALPROIC ACID;

ANALYTICAL ERROR; ANIMAL EXPERIMENT; ARTICLE; COGNITION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; LEARNING; MALE; NONHUMAN; RAT; RECEPTOR INTRINSIC ACTIVITY; TASK PERFORMANCE;

ANALYSIS OF VARIANCE; ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; MALE; MUSCARINIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY); SCOPOLAMINE; SERIAL LEARNING;

EID: 33846374750     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2006.11.004     Document Type: Article

References (37)

1. Perrine K., and Kiolbasa T. Cognitive deficits in epilepsy and contribution to psychopathology. Neurology 53 Suppl. 2 (1999) S39-S48
2. Meador K.J. Current discoveries on the cognitive effects of antiepileptic drugs. Pharmacotherapy 20 (2000) 185S-190S
3. Kwan P., and Brodie M.J. Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 357 (2001) 216-222
4. Martin R.C., Griffith H.R., Faught E., Gilliam F., Mackey M., and Vogtle L. Cognitive functioning in community dwelling older adults with chronic partial epilepsy. Epilepsia 46 (2005) 298-303
5. Smith D.B., Mattson R.H., Cramer J.A., et al. Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone. Epilepsia 28 Suppl. 3 (1987) S50-S58
6. Meador K.J., Loring D.W., Huh K., Gallagher B.B., and King D.W. Comparative cognitive effects of anticonvulsants. Neurology 40 (1990) 391-394
7. Meador K.J., Loring D.W., Moore E.E., et al. Comparative cognitive effects of phenobarbital, phenytoin and valproate in healthy adults. Neurology 45 (1995) 1494-1499
8. Martin R., Kuzniecky R., Hetherington H., et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 52 (1999) 321-327
9. Meador K.J., Loring D.W., Ray P.G., et al. Differential cognitive effects of carbamazepine and gabapentin. Epilepsia 40 (1999) 1279-1285
10. Shannon H.E., and Love P.L. Effects of antiepileptic drugs on working memory as assessed by spatial alternation performance in rats. Epilepsy Behav 5 (2004) 857-865
11. Shannon H.E., and Love P.L. Effects of antiepileptic drugs on attention as assessed by a 5-choice serial reaction time task in rats. Epilepsy Behav 7 (2005) 620-628
12. Aldenkamp A.P., Alpherts W.C., Dekker M.J., and Overweg J. Neuropsychological aspects of learning disabilities in epilepsy. Epilepsia 31 Suppl. 4 (1990) S9-S20
13. Cohn J., and Paule M.G. Repeated acquisition of response sequences: the analysis of behavior in transition. Neurosci Biobehav Rev 19 (1995) 397-406
14. Weinberger S.B., and Killam E.K. Alterations in learning performance in the seizure-prone baboon: effects of elicited seizures and chronic treatment with diazepam and phenobarbital. Epilepsia 19 (1978) 301-316
15. Paule M.G., and Killam E.K. Behavioral toxicity of chronic ethosuximide and sodium valproate treatment in the epileptic baboon Papio papio. J Pharmacol Exp Ther 238 (1986) 32-38
16. Thompson D.M. Repeated acquisition as a behavioral base line for studying drug effects. J Pharmacol Exp Ther 184 (1973) 506-514
17. Picker M., and Poling A. Effects of anticonvulsants on learning: performance of pigeons under a repeated acquisition procedure when exposed to phenobarbital, clonazepam, valproic acid, ethosuximide and phenytoin. J Pharmacol Exp Ther 230 (1984) 307-316
18. Poling A., Blakely E., White W., and Picker M. Chronic effects of clonazepam, phenytoin, ethosuximide and valproic acid on learning in pigeons as assayed by a repeated acquisition procedure. Pharmacol Biochem Behav 24 (1986) 1583-1586
19. Shannon H.E., and Love P.L. Within-session repeated acquisition behavior in rats as a potential model of executive function. Eur J Pharmacol 498 (2004) 125-134
20. Thompson D.M., and Moerschbaecher J.M. Drug effects on repeated acquisition. In: Thompson T., and Dews P.B. (Eds). Advances in behavioral pharmacology (1979), Academic Press, New York 229-259
21. Shannon H.E., Eberle E.L., and Peters S.C. Comparison of the effects of antiepileptic drugs with diverse mechanisms of action in the formalin test in rats. Neuropharmacology 48 (2005) 1012-1020
22. Barton M.E., Klein B.D., Wolf H.H., and White H.S. Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy. Epilepsy Res 47 (2001) 217-227
23. Meador K.J., Loring D.W., Huh K., et al. Comparative cognitive effects of carbamazepine and phenytoin in healthy adults. Neurology 41 (1991) 1537-1540
24. Meador K.J., Loring D.W., Abney O.L., et al. Effects of carbamazepine and phenytoin on EEG and memory in healthy adults. Epilepsia 34 (1993) 153-157
25. Goldberg J.F., and Burdick K.E. Cognitive side effects of anticonvulsants. J Clin Psychiatry 62 Suppl. 14 (2001) 27-33
26. Trimble M.R., and Thompson P.J. Sodium valproate and cognitive function. Epilepsia 25 Suppl. 1 (1984) S60-S64
27. Löscher W. Basic pharmacology of valproate. CNS Drugs 16 (2002) 669-694
28. Meador K.J., Loring D.W., Ray P.G., et al. Differential cognitive and behavioral effects of carbamazepine and lamotrigine. Neurology 56 (2001) 1177-1182
29. Pressler R.M., Binnier C.D., Coleshill S.G., Chorley G.A., and Robinson R.O. Effect of lamotrigine on cognition in children with epilepsy. Neurology 66 (2006) 1495-1499
30. Meador K.J., Loring D.W., Vahle V.J., et al. Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers. Neurology 64 (2005) 2108-2114
31. Crawford P. An audit of topiramate use in a general neurology clinic. Seizure 7 (1998) 207-211
32. Gerber P.E., Hamiwka L., Connolly M.B., and Farrell K. Factors associated with behavioral and cognitive abnormalities in children receiving topiramate. Pediatr Neurol 22 (2000) 200-203
33. Lee S., Sziklas V., Andermann F., et al. The effects of adjunctive topiramate on cognitive function in patients with epilepsy. Epilepsia 44 (2003) 339-347
34. Mecarelli O., Vicenzini E., Pulitano P., et al. Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers. Ann Pharmacother 38 (2004) 1816-1822
35. Neyens L.G.J., Alpherts W.C.J., and Aldenkamp A.P. Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy. Prog Neuro-Psychopharmacol Biol Psychiatry 19 (1995) 411-419
36. Cramer J.A., Arrigo C., Van Hammee G., Gauer L.J., and Cereghino J.J. Effect of levetiracetam on epilepsy-related quality of life. Epilepsia 41 (2000) 868-874
37. Löscher W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs: a comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res 50 (2002) 105-123